GZMK and neoplasm: Cytotoxic CD4+ phenotypes (i.e., GZMB+, GZMK+, Prolif which is largely cytotoxic, and MAIT) comprised the vast majority of CD4+ cells in blood that matched a TCR with tumor (Figure 2A).